📰 Human Use News
Page 29 - Human Use News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Human Use. Real-time updates on events, politics, business and more.
December 14, 2023
Apellis Pharmaceuticals Inc. (APLS), Thursday, announced that it expects the European Medicines Agency's Committee for Medicinal Products for Human Use, or CHMP, to adopt a negative opinion on the authorization application of intravitreal Pegcetacoplan.
December 14, 2023
Apellis Pharmaceuticals Inc APLS announced an update on the ongoing review of its marketing application for intravitreal pegcetacoplan for geographic atrophy…
December 14, 2023
Shares of Apellis Pharmaceuticals, Inc. (APLS) are falling more than 21 percent Thursday morning after the company said it expects the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) to give a negative opinion on its marketing authorization application for Pegcetacoplan to treat geographic atrophy.
December 13, 2023
The drug targets a mast cell mutation that gives rise to indolent systemic mastocytosis, a rare and debilitating blood disorder.
December 12, 2023
Following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), and the recommendation sent by EMA to the European Committee (EC), the EC has granted Marketing Authorisation to Bracco Imaging for its Vueway (gadopiclenol) contrast agent in the European Union
December 11, 2023
First-in-class treatment option reduces number and intensity of hot flashes and night sweats TOKYO, Dec. 10, 2023 /PRNewswire/ -- Astellas Pharma Inc. today announced the European Commission on...
December 11, 2023
A treatment option to reduce the number and intensity of hot flashes and night sweats associated with menopause has been approved by the European Commission (EC).
December 11, 2023
Following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), and the recommendation sent...
December 11, 2023
Following the positive opinion of the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA), and the recommendation sent...
December 9, 2023
/PRNewswire/ -- Blueprint Medicines Corporation (Nasdaq: BPMC) today announced data showcasing its commitment to advance the scientific understanding and...